<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>Converted by EDGARwiz</TITLE>
<META NAME="author" CONTENT="Roseann Sierchio">
<META NAME="date" CONTENT="01/09/2009">
</HEAD>
<BODY style="line-height:12pt; font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:468pt"><P style="line-height:23pt; margin:0pt; font-size:14pt" align=center><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
<P style="line-height:17pt; margin:0pt" align=center><B>Washington, D.C. &nbsp;20549</B></P>
<P style="margin:0pt"><BR></P>
<P style="line-height:20pt; margin:0pt; font-size:12pt" align=center><B>FORM 8-K</B></P>
<P style="margin:0pt"><BR></P>
<P style="line-height:17pt; margin:0pt" align=center><B>CURRENT REPORT</B></P>
<P style="margin:0pt"><BR></P>
<P style="line-height:17pt; margin:0pt" align=center>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</P>
<P style="margin:0pt"><BR></P>
<P style="line-height:18.5pt; margin:0pt; font-size:11pt" align=center><B><U>January 6, 2009</U></B></P>
<P style="line-height:14pt; margin:0pt; font-size:8pt" align=center>Date of Report (Date of earliest event reported)</P>
<P style="margin:0pt"><BR></P>
<P style="line-height:26pt; margin:0pt; font-size:16pt" align=center><B><U>PhytoMedical Technologies, Inc.</U></B></P>
<P style="line-height:14pt; margin:0pt; font-size:8pt" align=center>(Exact name of registrant as specified in its charter)</P>
<P style="margin:0pt"><BR></P>
<P style="line-height:17pt; margin:0pt" align=center><B><U>Nevada</U></B></P>
<P style="line-height:14pt; margin:0pt; font-size:8pt" align=center>(State or other jurisdiction of incorporation)</P>
<P style="margin:0pt"><BR></P>
<P style="line-height:normal; margin:0pt" align=center><B><U>000-28790</U></B> </P>
<P style="line-height:14pt; margin:0pt; font-size:8pt" align=center>(Commission File Number)</P>
<P style="margin:0pt"><BR></P>
<P style="line-height:normal; margin:0pt" align=center><B><U>87-0429962</U></B> </P>
<P style="line-height:14pt; margin:0pt; font-size:8pt" align=center>(I.R.S. Employer Identification No.)</P>
<P style="line-height:normal; margin:0pt" align=center><BR>
<B><U>100 Overlook Drive, 2nd Floor, Princeton, NJ &nbsp;08540</U></B> </P>
<P style="line-height:14pt; margin:0pt; font-size:8pt" align=center>(Address of principal executive offices)</P>
<P style="margin:0pt"><BR></P>
<P style="line-height:17pt; margin:0pt" align=center><B><U>(800) 611-3388</U></B></P>
<P style="line-height:14pt; margin:0pt; font-size:8pt" align=center>&nbsp;(Registrant&#146;s telephone number, including area code)</P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</P>
<P style="margin:0pt"><BR></P>
<P style="line-height:17pt; margin:0pt">[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>
<P style="line-height:17pt; margin:0pt">[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>
<P style="line-height:17pt; margin:0pt">[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>
<P style="line-height:17pt; margin:0pt">[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt"><BR>
<BR></P>
<P style="margin:0pt" align=center>1</P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt"><BR></P>
<HR style="margin-top:7.2pt; margin-bottom:7.2pt" noshade size=1.333>
<P style="margin:0pt; page-break-before:always"><B>SECTION 1. Registrant's Business and Operations</B></P>
<P style="margin:0pt"><BR></P>
<P style="line-height:13pt; margin:0pt; font-size:11pt"><U>Item 1.02. &nbsp;Termination of a Material Definitive Agreement</U></P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt; text-indent:36pt">On January 6, 2009, our wholly owned subsidiary Polyphenol Technologies Corporation (&#147;PTC&#148;) gave written notice to &nbsp;Iowa State University Research Foundation, Inc. (&#147;ISURF&#148;) terminating the License Agreement (ISURF #3313) between PTC and ISURF. The termination is effective April 6, 2009. &nbsp;</P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt; text-indent:36pt">On January 6, 2009, PTC also gave written notice to Iowa State University (&#147;ISU&#148;) terminating the Sponsored Research Agreement (ISU ID #87135) between PTC and ISU. The Termination is effective March 6, 2009.</P>
<P style="margin:0pt" align=justify><BR></P>
<P style="margin:0pt"><B>SECTION 2. &nbsp;Financial Information</B></P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt" align=justify>None.</P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt"><B>SECTION 3. &nbsp;Securities and Trading Markets</B></P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt">None.</P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt"><B>SECTION 4. &nbsp;Matters Related to Accountants and Financial Statements</B></P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt" align=justify>None.</P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt"><B>SECTION 5. &nbsp;Corporate Governance and Management</B></P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt" align=justify>None.</P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt" align=justify><B>SECTION 6. [Reserved]</B></P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt">N/A.</P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt" align=justify><B>SECTION 7. &nbsp;Regulation FD</B></P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt" align=justify>None.</P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt" align=justify><B>SECTION 8. &nbsp;Other Events</B></P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt">None.</P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt" align=justify><B>SECTION 9. &nbsp;Financial Statements and Exhibits<A NAME="part_1_2_1"></A><A NAME="item_1_47_1"></A></B></P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt">None.</P>
<A NAME="part_1_2_2"></A><P style="margin:0pt"><BR></P>
<P style="margin:0pt; padding-left:144pt; text-indent:36pt"><B>&nbsp;&nbsp;&nbsp;</B></P>
<P style="margin:0pt" align=center><B>SIGNATURES</B></P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt" align=justify>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on January 9, 2009.</P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt; text-indent:216pt"><B>PHYTOMEDICAL TECHNOLOGIES, INC.</B></P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt" align=center>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>/s/Greg Wujek___</U></P>
<P style="margin:0pt; text-indent:216pt">Greg Wujek</P>
<P style="margin:0pt; text-indent:216pt">President and CEO</P>
<P style="margin:0pt; text-indent:-72pt">&nbsp;</P>
<P style="line-height:14pt; margin:0pt; text-indent:360pt; font-size:12pt" align=justify><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P>
<P style="margin:0pt" align=justify><BR>
<BR></P>
<P style="margin:0pt" align=center>1</P>
<P style="margin:0pt"><BR></P>
<P style="margin:0pt"><BR></P>
</DIV></BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "f090105phytomedical8kfinal.htm", "secsgml_size_bytes": 7553}]
{"company-data": {"conformed-name": "PHYTOMEDICAL TECHNOLOGIES INC", "cik": "0001002422", "assigned-sic": "8093", "irs-number": "870429962", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-28790", "film-number": "09518161"}, "business-address": {"street1": "100 OVERLOOK DRIVE", "street2": "2ND FLOOR", "city": "PRINCETON", "state": "NJ", "zip": "08540", "phone": "604-659-5004"}, "mail-address": {"street1": "100 OVERLOOK DRIVE", "street2": "2ND FLOOR", "city": "PRINCETON", "state": "NJ", "zip": "08540"}, "former-company": [{"former-conformed-name": "ENTERPRISE TECHNOLOGIES INC", "date-changed": "20021220"}, {"former-conformed-name": "MEDCARE TECHNOLOGIES INC", "date-changed": "19960917"}]}
Converted by EDGARwiz
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
January 6, 2009
Date of Report (Date of earliest event reported)
PhytoMedical Technologies, Inc.
(Exact name of registrant as specified in its charter)
Nevada
(State or other jurisdiction of incorporation)
000-28790
(Commission File Number)
87-0429962
(I.R.S. Employer Identification No.)
100 Overlook Drive, 2nd Floor, Princeton, NJ  08540
(Address of principal executive offices)
(800) 611-3388
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
SECTION 1. Registrant's Business and Operations
Item 1.02.  Termination of a Material Definitive Agreement
On January 6, 2009, our wholly owned subsidiary Polyphenol Technologies Corporation ("PTC") gave written notice to  Iowa State University Research Foundation, Inc. ("ISURF") terminating the License Agreement (ISURF #3313) between PTC and ISURF. The termination is effective April 6, 2009.
On January 6, 2009, PTC also gave written notice to Iowa State University ("ISU") terminating the Sponsored Research Agreement (ISU ID #87135) between PTC and ISU. The Termination is effective March 6, 2009.
SECTION 2.  Financial Information
None.
SECTION 3.  Securities and Trading Markets
None.
SECTION 4.  Matters Related to Accountants and Financial Statements
None.
SECTION 5.  Corporate Governance and Management
None.
SECTION 6. [Reserved]
N/A.
SECTION 7.  Regulation FD
None.
SECTION 8.  Other Events
None.
SECTION 9.  Financial Statements and Exhibits
None.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on January 9, 2009.
PHYTOMEDICAL TECHNOLOGIES, INC.
/s/Greg Wujek___
Greg Wujek
President and CEO
1